Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th By: ACCESSWIRE October 13, 2022 at 10:30 AM EDT REDWOOD CITY, CA / ACCESSWIRE / October 13, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois. American Medical Device Summit: Location: Westin Chicago Lombard, Chicago, IllinoisFormat: Panel Discussion "The Evolving Role of Medical Devices in Delivering At-Home Patient Care"Date: Wednesday, October 19th at 4:20 p.m. - 4:55 p.m. CST The American Medical Device Summit provides insights and strategies to enhance the professional development of executives involved in the design, product development, innovation, technology and quality/ regulatory aspects of medical devices. The event will bring together 40 sponsors, 50+ speakers and 200 attendees - VPs and Directors of Design, Product Development, Innovation, Quality and Regulatory, etc. - to explore current trends and case studies. About Biotricity Inc. Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com. Investor Relations: Investor Relations:Biotricity Inc.(800) 590-4155investors@biotricity.com KCSA Strategic CommunicationsValter Pinto or Jack Perkins (212) 896-1254Investors@biotricity.com Media Contacts: Erica Fiorini, Russo Partners(212) 845-4253Erica.Fiorini@russopartnersllc.com SOURCE: Biotricity, Inc. View source version on accesswire.com: https://www.accesswire.com/720330/Biotricity-CEO-Waqaas-Al-Siddiq-to-Participate-in-Panel-Discussion-on-the-Evolution-of-Medical-Devices-at-the-American-Medical-Device-Summit-on-October-19th Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th By: ACCESSWIRE October 13, 2022 at 10:30 AM EDT REDWOOD CITY, CA / ACCESSWIRE / October 13, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois. American Medical Device Summit: Location: Westin Chicago Lombard, Chicago, IllinoisFormat: Panel Discussion "The Evolving Role of Medical Devices in Delivering At-Home Patient Care"Date: Wednesday, October 19th at 4:20 p.m. - 4:55 p.m. CST The American Medical Device Summit provides insights and strategies to enhance the professional development of executives involved in the design, product development, innovation, technology and quality/ regulatory aspects of medical devices. The event will bring together 40 sponsors, 50+ speakers and 200 attendees - VPs and Directors of Design, Product Development, Innovation, Quality and Regulatory, etc. - to explore current trends and case studies. About Biotricity Inc. Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com. Investor Relations: Investor Relations:Biotricity Inc.(800) 590-4155investors@biotricity.com KCSA Strategic CommunicationsValter Pinto or Jack Perkins (212) 896-1254Investors@biotricity.com Media Contacts: Erica Fiorini, Russo Partners(212) 845-4253Erica.Fiorini@russopartnersllc.com SOURCE: Biotricity, Inc. View source version on accesswire.com: https://www.accesswire.com/720330/Biotricity-CEO-Waqaas-Al-Siddiq-to-Participate-in-Panel-Discussion-on-the-Evolution-of-Medical-Devices-at-the-American-Medical-Device-Summit-on-October-19th
REDWOOD CITY, CA / ACCESSWIRE / October 13, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois. American Medical Device Summit: Location: Westin Chicago Lombard, Chicago, IllinoisFormat: Panel Discussion "The Evolving Role of Medical Devices in Delivering At-Home Patient Care"Date: Wednesday, October 19th at 4:20 p.m. - 4:55 p.m. CST The American Medical Device Summit provides insights and strategies to enhance the professional development of executives involved in the design, product development, innovation, technology and quality/ regulatory aspects of medical devices. The event will bring together 40 sponsors, 50+ speakers and 200 attendees - VPs and Directors of Design, Product Development, Innovation, Quality and Regulatory, etc. - to explore current trends and case studies. About Biotricity Inc. Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com. Investor Relations: Investor Relations:Biotricity Inc.(800) 590-4155investors@biotricity.com KCSA Strategic CommunicationsValter Pinto or Jack Perkins (212) 896-1254Investors@biotricity.com Media Contacts: Erica Fiorini, Russo Partners(212) 845-4253Erica.Fiorini@russopartnersllc.com SOURCE: Biotricity, Inc. View source version on accesswire.com: https://www.accesswire.com/720330/Biotricity-CEO-Waqaas-Al-Siddiq-to-Participate-in-Panel-Discussion-on-the-Evolution-of-Medical-Devices-at-the-American-Medical-Device-Summit-on-October-19th